Major Bladder Procedures with CC DRG Reimbursement Guide

DRG 654 encompasses major bladder procedures performed with a Complication or Comorbidity and defines the inpatient clinical scope for complex bladder surgery billing. Correct assignment affects Medicare inpatient reimbursement by reflecting higher resource intensity when complications or comorbid conditions are present.

DRG 654 Overview

DRG 654 covers hospital admissions for major bladder procedures when a Complication or Comorbidity is present, including cystectomy with complex reconstruction or extensive bladder surgery. This Diagnosis-Related Group groups clinically similar cases with comparable resource use for Medicare payment. It matters because the presence of a Complication or Comorbidity increases expected resource consumption and influences inpatient reimbursement under Medicare. Hospitals and coders must correctly identify procedures and associated diagnoses to ensure accurate assignment to this Diagnosis-Related Group.

Perioperative optimization and enhanced recovery protocols for patients undergoing major bladder procedures with CC: randomized or pragmatic studies comparing different preoperative and intraoperative care bundles (eg, fluid management, analgesia pathways, and infection prevention strategies) in adults undergoing open or minimally invasive cystectomy or other major bladder surgeries complicated by comorbid conditions. These trials enroll patients with significant comorbidities (eg, cardiac, pulmonary, renal dysfunction, or active infection) who drive the CC classification and examine short-term perioperative morbidity, length of stay, and readmission. Results are highly relevant to providers and payers because reducing complications and LOS directly affects inpatient resource use, costs, and readmission penalties.
Comparative effectiveness research on surgical approaches and reconstruction techniques in complex bladder procedures: multicenter observational cohorts or randomized trials comparing open versus robotic-assisted approaches, different urinary diversion types, or reconstruction timing in patients with high comorbidity burden or prior pelvic surgery/radiation. These studies focus on intermediate outcomes such as complication rates, need for reoperation, functional outcomes (eg, continence), and resource utilization in the higher-risk population captured by this DRG. Payers and health systems use this evidence to inform coverage decisions, network referral patterns, and bundled payment designs aimed at optimizing value for complex surgical patients.
Post-discharge outcomes and long-term survivorship studies evaluating readmissions, complication trajectories, and patient-reported outcomes after major bladder procedures: prospective registries or longitudinal cohort studies tracking patients from hospital discharge through 6–24 months, with emphasis on those with complicating comorbidities or postoperative complications. Research questions include predictors of early and late readmission, durable functional outcomes, need for home health or durable medical equipment, and costs of ongoing care in medically complex patients. Findings inform care-transition programs, post-acute care placement strategies, and payer investments in outpatient support to reduce avoidable utilization and improve long-term outcomes for this high-cost DRG.

Perioperative optimization and enhanced recovery protocols for patients undergoing major bladder procedures with CC: randomized or pragmatic studies comparing different preoperative and intraoperative care bundles (eg, fluid management, analgesia pathways, and infection prevention strategies) in adults undergoing open or minimally invasive cystectomy or other major bladder surgeries complicated by comorbid conditions. These trials enroll patients with significant comorbidities (eg, cardiac, pulmonary, renal dysfunction, or active infection) who drive the CC classification and examine short-term perioperative morbidity, length of stay, and readmission. Results are highly relevant to providers and payers because reducing complications and LOS directly affects inpatient resource use, costs, and readmission penalties.
Comparative effectiveness research on surgical approaches and reconstruction techniques in complex bladder procedures: multicenter observational cohorts or randomized trials comparing open versus robotic-assisted approaches, different urinary diversion types, or reconstruction timing in patients with high comorbidity burden or prior pelvic surgery/radiation. These studies focus on intermediate outcomes such as complication rates, need for reoperation, functional outcomes (eg, continence), and resource utilization in the higher-risk population captured by this DRG. Payers and health systems use this evidence to inform coverage decisions, network referral patterns, and bundled payment designs aimed at optimizing value for complex surgical patients.
Post-discharge outcomes and long-term survivorship studies evaluating readmissions, complication trajectories, and patient-reported outcomes after major bladder procedures: prospective registries or longitudinal cohort studies tracking patients from hospital discharge through 6–24 months, with emphasis on those with complicating comorbidities or postoperative complications. Research questions include predictors of early and late readmission, durable functional outcomes, need for home health or durable medical equipment, and costs of ongoing care in medically complex patients. Findings inform care-transition programs, post-acute care placement strategies, and payer investments in outpatient support to reduce avoidable utilization and improve long-term outcomes for this high-cost DRG.

OpenPayer

Summary & Overview

Major Bladder Procedures with CC: Inpatient Reimbursement Overview

DRG 654 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes